NASDAQ: IRD
Opus Genetics Inc Stock Ownership - Who owns Opus Genetics?

Insider buying vs selling

Have Opus Genetics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
George MagrathCEO2026-11-0328,258$3.90
$110.18kSell
Benjamin R. YerxaPres2026-10-237,669$3.55
$27.23kSell
George MagrathCEO2026-10-239,591$3.59
$34.38kSell
Benjamin R. YerxaPres2026-10-2325,520$3.53
$90.14kSell
Joseph K. SchachleCOO2026-10-234,767$3.57
$16.99kSell
Robert E. GagnonCFO2026-10-2314,000$3.55
$49.64kSell
Foundation Fighting Blindness Retinal Degeneration FundDirector2026-09-30556,000$4.96
$2.76MSell
George MagrathCEO2026-09-09392,157$1.15
$450.98kBuy
George MagrathCEO2026-09-0975,541$5.97
$450.98kSell
Cam GallagherDirector2026-09-08784,314$1.15
$901.96kBuy

1 of 4

IRD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IRD insiders and whales buy or sell their stock.

IRD Shareholders

What type of owners hold Opus Genetics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Sungkee Chung169.47%163,800,000$668.30MInsider
Sung Sook Park72.63%70,200,000$286.42MInsider
Frank Ferraro26.90%26,000,000$106.08MInsider
Inok Ahn14.48%14,000,000$57.12MInsider
Chang Ho Ahn11.91%11,510,000$46.96MInsider
Rexgene Biotech Co Ltd5.70%5,505,956$22.46MInsider
Foundation Fighting Blindness Retinal Degeneration Fund3.35%3,236,171$13.20MInsider
Cam Gallagher3.07%2,966,111$12.10MInsider
Young Soon Park2.80%2,706,500$11.04MInsider
George Magrath2.08%2,010,636$8.20MInsider

1 of 3

IRD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IRD0.03%99.97%Net SellingNet Buying
EPRX0.05%0.00%
AVTX0.09%99.91%Net SellingNet Buying
RZLT0.08%99.92%Net BuyingNet Selling
PHAT0.09%41.16%Net SellingNet Selling

Opus Genetics Stock Ownership FAQ

Who owns Opus Genetics?

Opus Genetics (NASDAQ: IRD) is owned by 0.08% institutional shareholders, 319.41% Opus Genetics insiders, and 0.00% retail investors. Sungkee Chung is the largest individual Opus Genetics shareholder, owning 163.80M shares representing 169.47% of the company. Sungkee Chung's Opus Genetics shares are currently valued at $653.56M.

If you're new to stock investing, here's how to buy Opus Genetics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.